116
Views
11
CrossRef citations to date
0
Altmetric
ONCOLOGY

CD44 expression is related to poor prognosis of hypopharyngeal squamous cell carcinoma

, , , , , , , , , , , & show all
Pages 323-329 | Received 26 Jul 2010, Accepted 26 Sep 2010, Published online: 10 Dec 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Eugenia Allegra & Serena Trapasso. (2012) Cancer stem cells in head and neck cancer. OncoTargets and Therapy 5, pages 375-383.
Read now
Serena Trapasso & Eugenia Allegra. (2012) Role of CD44 as a marker of cancer stem cells in head and neck cancer. Biologics: Targets and Therapy 6, pages 379-383.
Read now

Articles from other publishers (9)

Lidia Puzzo, Maria Rita Bianco, Lucia Salvatorelli, Giordana Tinnirello, Federico Occhiuzzi, Daniele Latella & Eugenia Allegra. (2023) CD44, PDL1, and ATG7 Expression in Laryngeal Squamous Cell Carcinomas with Tissue Microarray (TMA) Technique: Evaluation of the Potential Prognostic and Predictive Roles. Cancers 15:9, pages 2461.
Crossref
Erin R. Cohen, Isildinha M. Reis, Carmen Gomez, Lutecia Pereira, Monika E. Freiser, Gia Hoosien & Elizabeth J. Franzmann. (2017) Immunohistochemistry Analysis of CD44, EGFR, and p16 in Oral Cavity and Oropharyngeal Squamous Cell Carcinoma. Otolaryngology–Head and Neck Surgery 157:2, pages 239-251.
Crossref
Andrew M. Baschnagel, Nathan Tonlaar, Mohammad Eskandari, Tripti Kumar, Lindsay Williams, Alaa Hanna, Barbara L. Pruetz & George D. Wilson. (2017) Combined CD44, c-MET, and EGFR expression in p16-positive and p16-negative head and neck squamous cell carcinomas. Journal of Oral Pathology & Medicine 46:3, pages 208-213.
Crossref
H. Yoshikawa, D. G. Maranon, C. L. R. Battaglia, E. J. Ehrhart, J. B. Charles, S. M. Bailey & S. M. LaRue. (2016) Predicting clinical outcome in feline oral squamous cell carcinoma: tumour initiating cells, telomeres and telomerase. Veterinary and Comparative Oncology 14:4, pages 371-383.
Crossref
K Sagawa, N Uwa, T Daimon, M Sakagami & T Tsujimura. (2016) Expression of CD44 variant isoforms, CD44v3 and CD44v6, are associated with prognosis in nasopharyngeal carcinoma. The Journal of Laryngology & Otology 130:9, pages 843-849.
Crossref
Jianqiang Chen, Jianding Zhou, Jie Lu, Hua Xiong, Xueli Shi & Liang Gong. (2014) Significance of CD44 expression in head and neck cancer: a systemic review and meta-analysis. BMC Cancer 14:1.
Crossref
Silvana Papagerakis, Giuseppe Pannone, Li Zheng, Imad About, Nawar Taqi, Nghia P.T. Nguyen, Margarite Matossian, Blake McAlpin, Angela Santoro, Jonathan McHugh, Mark E. Prince & Petros Papagerakis. (2014) Oral epithelial stem cells—Implications in normal development and cancer metastasis. Experimental Cell Research 325:2, pages 111-129.
Crossref
Anders Näsman, Cecilia Nordfors, Nathalie Grün, Eva Munck‐Wikland, Torbjörn Ramqvist, Linda Marklund, David Lindquist & Tina Dalianis. (2013) Absent/weak CD 44 intensity and positive human papillomavirus ( HPV ) status in oropharyngeal squamous cell carcinoma indicates a very high survival . Cancer Medicine 2:4, pages 507-518.
Crossref
Daniele Minardi, Guendalina Lucarini, Alessandra Filosa, Antonio Zizzi, Oriana Simonetti, Anna Maria Offidani, Gianluca d’Anzeo, Roberto Di Primio, Rodolfo Montironi & Giovanni Muzzonigro. (2012) Prognostic value of CD44 expression in penile squamous cell carcinoma: a pilot study. Cellular Oncology 35:5, pages 377-384.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.